Basilea reports positive preclinical data on oncology drug candidates derazantinib and lisavanbulin at AACR-NCI-EORTC conference

by NASDAQ Market News October 30, 2019

NASDAQ Market News
Click here to email author

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis, Trends, and Forecasts, 2019-2025 – Market to Witness Healthy Growth, Driven by Low-cost Advantages

Roche’s marketing applications for satralizumab in neuromyelitis optica spectrum disorder accepted for review by EMA and FDA

Ads